Tsc1 Loss in VIP-Lineage Cortical Interneurons Results in More VIP+ Interneurons and Enhanced Excitability

Area of Science:

• Neuroscience
• Cell Biology
• Genetics

Background:

• The mammalian target of rapamycin (mTOR) pathway regulates crucial cellular processes like proliferation and fate.
• mTOR's role in neurodevelopmental disorders is under active investigation.
• Previous studies linked Tsc1 loss and mTOR hyperactivity to altered medial ganglionic eminence-derived cortical interneurons (CINs).

Purpose of the Study:

• To investigate the impact of mTOR dysfunction on caudal ganglionic eminence-derived VIP+ interneurons.
• To determine if Tsc1 mutations affect VIP+ CINs and contribute to associated neurological conditions.

Main Methods:

• Genetic deletion of the Tsc1 gene in VIP+ CINs.
• Analysis of apoptosis patterns during postnatal development (days 15-20).
• Assessment of synaptic and electrophysiological properties of mutant CINs.

Main Results:

• Tsc1 mutant VIP+ CINs showed reduced apoptosis, leading to an increased number of these interneurons.
• Mutant CINs displayed altered synaptic and electrophysiological characteristics.
• These cellular changes correlate with seizure activity observed in Tsc1 mutation patients.

Conclusions:

• mTOR hyperactivity due to Tsc1 loss impacts VIP+ interneuron development and function.
• Dysfunctional VIP+ CINs are a potential mechanism underlying seizures in Tsc1-related disorders.
• This study highlights the specific vulnerability of distinct interneuron populations to mTOR pathway dysregulation.